¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÀåÇÐȸ 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2019-04-20

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÀåÇÐȸ 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2019-04-20
±³À°ÀÏÀÚ : 2019-04-20
±³À°Àå¼Ò : º¤½ºÄÚ 104È£ ¿Ü  
±³À°ÁÖÁ¦ : 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
´ã´çÀÚ : Á¶À±ÇÏ
¿¬¶ôó : 02-3275-5258  
À̸ÞÀÏ : herz8@circulation.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í »çÀüµî·Ï: ±³¼ö ¹× °³¿øÀÇ 100,000¿ø/ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ 70,000¿ø ´çÀϵî·Ï: ±³¼ö ¹× °³¿øÀÇ 120,000¿ø/ÀüÀÓÀÇ, Àü°øÀÇ, ±âŸ 90,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-20 104È£ 09:00~09:12 Vascular Access for Coronary Intervention - TFI, TRI, Distal Radial  ÀÌÁØ¿ø(¿¬¼¼¿øÁÖÀÇ´ë) 
±³À°½Ã°£ 04-20 104È£ 09:12~09:24 Vascular Access for Non-Coronary Intervention - TFI, TRI, Brachial, Others  °íÃæ¿ø(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 04-20 104È£ 09:24~09:36 Hemostasis: A to Z  ÇãÁ¤È£(°í½ÅÀÇ´ë) 
±³À°½Ã°£ 04-20 104È£ 09:36~09:48 How to Solve Access Site Problems  À¯»ó¿ë(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 04-20 104È£ 09:48~10:00 Tips & Tricks of Vascular Access  ÀÌÀçȯ(Ãæ³²ÀÇ´ë) 
Åä·Ð 04-20 104È£ 10:00~10:30 Discussion  () 
È޽Ġ04-20  10:30~10:40 Break  () 
±³À°½Ã°£ 04-20 203È£ 10:40~10:55 Role of Myocardial Strain Imaging in Acyanotic CHD  ¿ÀÁøÈñ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-20 203È£ 10:55~11:10 Funtional Assessment Before and after VAD in Children with CHD  Á¤¼¼¿ë(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-20 203È£ 11:10~11:25 How to Manage the Patients with Pulmonary Venous Obstruction in TAPVR : Pre-op & Post-op  ÀÌ»óÀ±(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-20 203È£ 11:25~11:55 Integrated Imaging Approach to Pulmonary Venous Obstruction  Shi-Joon Yoo(Univ. of Toronto Canada) 
Åä·Ð 04-20 203È£ 11:55~12:10 Discussion  () 
È޽Ġ04-20  12:10~12:15 Break  () 
±³À°½Ã°£ 04-20 201È£ 12:15~12:55 PIONEER-HF: Prime Time for ARNI in Stabilized AHF Patients  Eric Velazquez(Yale University USA) 
È޽Ġ04-20  12:55~13:10 Break  () 
±³À°½Ã°£ 04-20 205È£ 13:10~13:18 Pacing Maneuvers for SVT Differentiation  ±è¼ºÈ¯(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:18~13:26 Treatment of PSVT  ±èÁ¾À±(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:26~13:34 How I Overcame a Challenging Case of PSVT?  ¿À¼¼ÀÏ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:34~13:42 EKG localization: outflow VT  ÁøÀº¼±(°æÈñÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:42~13:50 EKG localization: non-outflow VT  ¿Â¿µ±Ù(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:50~13:58 Pharmacologic treatment of VT  ±èÀ¯¸®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 13:58~14:06 Neuromodulation in refractory ventricular arrhythmia  ¹Ú°æ¹Î(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 04-20 205È£ 14:06~14:14 New Technique and Technologies in VT Ablation  ±èÁØ(¿ï»êÀÇ´ë) 
Åä·Ð 04-20 205È£ 14:14~14:40 Discussion  () 
È޽Ġ04-20  14:40~14:50 Break  () 
±³À°½Ã°£ 04-20 103È£ 14:50~15:10 What Is the Best Prognosticator in HF?: Imaging vs. Biomarker  ÃÖÁ¤Çö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 04-20 103È£ 15:10~15:30 Cardiac Cath Will Guide the Course and Management for HF  ÀÌÁÖÈñ(ÃæºÏÀÇ´ë) 
±³À°½Ã°£ 04-20 103È£ 15:30~15:50 Imaging in Athletes: How to Differentiate with Pathology?  ¼±º´ÁÖ(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 04-20 103È£ 15:50~16:10 How to Use Cardiac Imaging for Therapeutic Guideline in HF  ¾çµ¿Çå(°æºÏÀÇ´ë) 
Åä·Ð 04-20 103È£ 16:10~16:20 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÀåÇÐȸ 2019 Ãá°è½ÉÇ÷°üÅëÇÕÇмú´ëȸ : 2019-04-20""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï´ëÇб³º´¿ø 2019³â Á¦19ȸ ´ëÇÑÀü¸³¼±·¹ÀÌÀú¿¬±¸ÇÐȸ ÁýÁß½ÉÆ÷Áö¿ò : 2019-04-20
´ÙÀ½±Û ´ëÇѾȽŰæÀÇÇÐȸ 2019³â Ãá°èÇмú´ëȸ (Neurology of eye movements) : 2019-04-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20340 ¼­¿ï Çѱ¹½ÇÇèÇ÷¾×ÇÐȸ 2024 KSEH Spring Meeting – Revolutionizing technologies to overcome hurdles of cancer research & therapy : 2024-05-17 0 90 2024-04-03
20339 ¼­¿ï (¿Â¶óÀÎ) À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-GERDÀÇ ÃÖ½ÅÄ¡·á-°¡À̵å¶óÀÎÀ» Áß½ÉÀ¸·Î : 2024-05-16 0 101 2024-04-03
20338 ºÎ»ê ´ëÇÑÀçÈ°ÀÇÇÐȸ Á¦164Â÷ ºÎ»ê¿ï»ê°æ³²Áöȸ Áý´ãȸ : 2024-05-16 0 119 2024-04-03
20337 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-05-13 0 134 2024-04-03
20336 ¼­¿ï Çѱ¹ÀÓ»ó°íÇ÷¾ÐÇÐȸ 2024³â Ãá°èÇмú¼¼¹Ì : 2024-05-12 0 180 2024-04-03
20335 ¼­¿ï ´ëÇѼö¸é¿¬±¸ÇÐȸ °³¿øÀÇ ¡¤ ºÀÁ÷ÀÇ ¿¬¼ö±³À° : 2024-05-12 0 174 2024-04-03
20334 ¼­¿ï 2024³â ¼­Ãʱ¸ÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-05-12 0 110 2024-04-03
20333 Ãæ³² Á¦10ȸ ¼øõÇâ´ëÇб³ÀÇ°ú´ëÇРõ¾Èº´¿ø ¼ÒÈ­±â³»°úÇб³½Ç ¼ÒÈ­±âº´ ½ÉÆ÷Áö¿ò : 2024-05-11 0 146 2024-04-03
20332 ¼­¿ï ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ : The 17th SMC Vascular Symposium, 2024 : 2024-05-11 0 104 2024-04-03
20331 ºÎ»ê Çѱ¹¿Ü°ú·Îº¿¼ö¼úÇÐȸ 2024 KAROS Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-05-10 0 91 2024-04-03
20330 ¼­¿ï 2024 °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ Áý´ãȸ : 2024-05-09 0 80 2024-04-03
20329 ¼­¿ï (¿Â¶óÀÎ) À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-½Å°æÅ뼺 ÀÌÅëÀÇ Æ¯Â¡°ú ¾à¹°Ã³¹æ ¿ä·É, ¾à¹° ÁÖÀÇ»çÇ× : 2024-05-09 0 107 2024-04-03
20328 ºÎ»ê Çѱ¹¿Ü°ú·Îº¿¼ö¼úÇÐȸ 2024 KAROS Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-05-09 0 143 2024-04-03
20327 ºÎ»ê 2024 ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ºÎ¿ï°æÁöȸ Áú°ü¸® ½ÉÆ÷Áö¿ò : 2024-05-04 0 115 2024-04-03
20326 °æ³² Á¦37Â÷ ´ëÇÑ´ç´¢º´ÇÐȸ Ãá°èÇмú´ëȸ(3ÀÏÂ÷) : 2024-05-04 0 69 2024-04-03
51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷